Mapp’s Ebola treatment comes through in a preclinical study

Damian Garde

Tiny Mapp Biopharmaceutical's much-scrutinized proved 100% effective in animal studies, the company said, stoking hopes that the investigational therapy can help curb an outbreak of the virus.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS